REVERSE RECAPITALIZATION (Tables)

12 Months Ended

Dec. 31, 2024

REVERSE RECAPITALIZATION

Schedule of reverse recapitalization


Cash - MCAC's trust and cash (net of redemption)					$	38,441,920
Less: transaction costs and advisory fees paid						(2,670,961)
Net Business Combination financing					$	35,770,959


Common stock, outstanding prior to Business Combination						3,898,781
Less: redemption of MCAC shares						(3,665,639)
Common stock of MCAC						233,142
MCAC founder shares						2,300,000
Rights issued to MCAC shareholders						920,000
Shares outstanding in connection with forward purchase agreement						3,248,466
Business Combination and forward purchase agreement financing shares						6,701,608
Legacy ConnectM shares						14,422,449
Total shares of common stock immediately after Business Combination						21,124,057
Issuance of shares of common stock after Business Combination						7,969,232
Total shares of common stock at December 31, 2024						29,093,289


			Legacy ConnectM shares			Legacy ConnectM shares, effected for Exchange Ratio
Recapitalization applied to common stock outstanding at December 31, 2022			1,588,141			5,274,587
Issuance of Old ConnectM shares prior to closing of Business Combination			5,000			16,607
Conversion of convertible notes payable to common stock prior to Business Combination			321,428			1,067,592
Recapitalization applied to Series Seed preferred stock outstanding at December 31, 2022			644,030			2,139,081
Recapitalization applied to Series Seed-1 preferred stock outstanding at December 31, 2022			91,120			302,645
Recapitalization applied to Series A-1 preferred stock outstanding at December 31, 2022			743,068			2,468,026
Recapitalization applied to Series B-1 preferred stock outstanding at December 31, 2022			649,843			2,158,388
Recapitalization applied to Series B-2 preferred stock outstanding at December 31, 2022			299,730			995,523
						14,422,449